Hemp Extract Cbd Isolate Powder 99% 99.9% 98% CAS 13956-29-1 Cbd Cannabidiol Oil

China Hemp Extract Cbd Isolate Powder 99% 99.9% 98% CAS 13956-29-1 Cbd Cannabidiol Oil, Find details about China Cannabidiol, Cbd Isolate Powder from Hemp Extract Cbd Isolate Powder 99% 99.9% 98% CAS 13956-29-1 Cbd Cannabidiol Oil

Basic Info.

Model NO.

13956-29-1

Wickr

Bellachen

Common Name

Cannabidiol

CAS Number

13956-29-1

Molecular Weight

314.462

Boiling Point

463.9±45.0 °c at 760 Mmhg

Melting Point

62-63°c

Flash Point

206.3±23.3 °c

Molecular Formula

C21h30o2

Density

1.0±0.1 g/cm3

Trademark

Hanhong

Transport Package

Customized

Specification

Customized

Origin

China

Model NO.

13956-29-1

Wickr

Bellachen

Common Name

Cannabidiol

CAS Number

13956-29-1

Molecular Weight

314.462

Boiling Point

463.9±45.0 °c at 760 Mmhg

Melting Point

62-63°c

Flash Point

206.3±23.3 °c

Molecular Formula

C21h30o2

Density

1.0±0.1 g/cm3

Trademark

Hanhong

Transport Package

Customized

Specification

Customized

Origin

China

Product Desciption

Hemp Extract Cbd Isolate Powder 99% 99.9% 98% CAS 13956-29-1 Cbd Cannabidiol Oil

CANNABIDIOL Chemical Properties

Melting point	62-63°C
alpha	D27 -125° (0.066 g in 5 ml 95% ethanol); D18 -129° (c = 0.45 in ethanol)
Boiling point	bp2 187-190° (bath temp 220°); bp0.001 130°
density	d440 1.040
refractive index	nD20 1.5404
Fp	11 °C
storage temp.	2-8°C
InChIKey	QHMBSVQNZZTUGM-ZWKOTPCHSA-N

CANNABIDIOL Usage And Synthesis

Overview

Cannabidiol[CBD] is the main non-psychotropic component of the glandular. It displays a plethora of actions including anticonvulsive, sedative, hypnotic, antipsychotic, and anti-inflammatory and neuroprotective properties. Although the exact medical implications are currently being investigated, CBD has shown promise as a therapeutic and pharmaceutical drug target. In particular, CBD has shown promise as an analgesic, anticonvulsant, muscle relaxant, anxiolytic, antipsychotic and has shown neuroprotective, anti-inflammatory, and antioxidant activity, among other currently investigated uses^{[1, 2]}.
Cannabidiol was isolated in the late 1930s, but only in the 1963 were its structure and stereochemistry first elucidated^[3]. Early studies focusing on CBD pharmacology started in the 1970s, with the first relevant finding concerning its hypnotic and anticonvulsant properties, published in 1981^[4]. Since then, a large body of pharmacological effects has been demonstrated, both in preclinical and in clinical studies.

Figure 1 the chemical structure of Cannabidiol;

Indication

Being used in combination with delta-9-tetrahydrocannabinol as the product Sativex, cannabidiol was applied for the following indications: 1) as adjunctive treatment for symptomatic relief of spasticity in adult patients with multiple sclerosis[MS] who have not responded adequately to other therapy and who demonstrate meaningful improvement during an initial trial of therapy ^[7]; Sativex was also given a Notice of Compliance with Conditions(NOC/c) by Health Canada for the following indications: 1) as adjunctive treatment for the symptomatic relief of neuropathic pain in adult patients with multiple sclerosis; 2) as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain^[7].

Hemp Extract Cbd Isolate Powder 99% 99.9% 98% CAS 13956-29-1 Cbd Cannabidiol Oil